Stocks
Nektar Therapeutics (NKTR) EBITDA margin US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | -453.2% | -351.8% | -269.8% | -88.1% | -248.1% | -215.9% | ||
| Changes by years, y/y, % | -195pp | +101pp | +82pp | +182pp | -160pp | -0.8% | |||
Nektar Therapeutics. EBITDA margin, %
Nektar Therapeutics. EBITDA margin, changes, pp
Nektar Therapeutics (NKTR) EBITDA margin US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| EBITDA margin, % | ? | -248.6% | -119.6% | -338.3% | -630.4% | -416.9% | -215.9% | |
| Changes by years, y/y, % | -124pp | -180pp | +53pp | -328pp | -115pp | |||
| Changes by quarters, q/q, % | +54pp | +129pp | -219pp | -292pp | +213pp | |||
